Literature DB >> 22778209

Multi-territory ischaemic strokes and subacute bacterial endocarditis.

Shahideh Safavi1, Michelle Tufnell, Ajay Bhalla.   

Abstract

We describe an elderly patient presenting with cardio-embolic stroke who was found to have infective endocarditis (IE) affecting the mitral valve. Penicillin-resistant Facklamia hominis was identified as the causative pathogen. Despite initiation of aggressive antibiotic treatment, the patient suffered a fatal myocardial infarction 2 days post-diagnosis of IE. Facklamia spp. have not been previously reported to be associated with IE. Here, we discuss the link between IE and cardio-embolic stroke along with a discussion of various causative pathogens.

Entities:  

Mesh：

Year:  2010        PMID： 22778209      PMCID： PMC3028262          DOI： 10.1136/bcr.06.2009.2023

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  7 in total

1.  Antimicrobial susceptibilities and clinical sources of Facklamia species.

Authors:  L LaClaire; R Facklam
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Phenotypic and phylogenetic characterization of some Globicatella-like organisms from human sources: description of Facklamia hominis gen. nov., sp. nov.

Authors:  M D Collins; E Falsen; J Lemozy; E Akervall; B Sjödén; P A Lawson
Journal:  Int J Syst Bacteriol       Date:  1997-07

3.  Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland.

Authors:  M Heiro; J Nikoskelainen; E Engblom; E Kotilainen; R Marttila; P Kotilainen
Journal:  Arch Intern Med       Date:  2000-10-09

4.  The role of 16S rRNA gene sequencing in identification of microorganisms misidentified by conventional methods.

Authors:  C A Petti; C R Polage; P Schreckenberger
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors:  D T Durack; A S Lukes; D K Bright
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

6.  Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study.

Authors:  Franck Thuny; Jean-François Avierinos; Christophe Tribouilloy; Roch Giorgi; Jean-Paul Casalta; Loïc Milandre; Amel Brahim; Georges Nadji; Alberto Riberi; Frédéric Collart; Sebastien Renard; Didier Raoult; Gilbert Habib
Journal:  Eur Heart J       Date:  2007-03-15       Impact factor: 29.983

7.  The "incubation period" of subacute bacterial endocarditis.

Authors:  M Starkebaum; D Durack; P Beeson
Journal:  Yale J Biol Med       Date:  1977 Jan-Feb
  7 in total
  5 in total

1.  Facklamia hominis scapula abscess, Marseille, France.

Authors:  C Abat; V Garcia; J-M Rolain
Journal:  New Microbes New Infect       Date:  2015-11-14

2.  Facklamia Species as an Underrecognized Pathogen.

Authors:  Elham Rahmati; Vanessa Martin; Darren Wong; Fred Sattler; Jonas Petterson; Pamela Ward; Susan M Butler-Wu; Rosemary C She
Journal:  Open Forum Infect Dis       Date:  2017-01-09       Impact factor: 3.835

3.  Facklamia hominis bacteremia after transurethral resection of the prostate: a case report.

Authors:  Miriam Gahl; Thomas Stöckli; René Fahrner
Journal:  BMC Urol       Date:  2020-12-07       Impact factor: 2.264

Review 4.  Facklamia hominis pyelonephritis in a pediatric patient: first case report and review of the literature.

Authors:  Samantha Pérez-Cavazos; Daniela Cisneros-Saldaña; Fernando Espinosa-Villaseñor; José Iván Castillo-Bejarano; Denisse Natalie Vaquera-Aparicio; Hugo Sánchez-Alanís; Abiel Mascareñas-De Los Santos
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-02-12       Impact factor: 3.944

5.  Infective endocarditis: a rare organism in an uncommon setting.

Authors:  Rajiv Ananthakrishna; Ravindranath K Shankarappa; Naveena Jagadeesan; Ravi S Math; Satish Karur; Manjunath C Nanjappa
Journal:  Case Rep Infect Dis       Date:  2012-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.